Young people in England aged 12-15 to be offered COVID-19 vaccine

Young people in England aged 12-15 to be offered COVID-19 vaccine

The Health and Social Care Secretary has announced that people aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech...
UK government terminates COVID-19 vaccine agreement with Valneva

UK Government terminates COVID-19 vaccine agreement with Valneva

The French speciality vaccine company, Valneva, has announced that it has received a termination notice from the UK Government in relation to the Supply...
JCVI issues advice on third dose COVID-19 vaccination for severely immunosuppressed

JCVI issues advice on third dose COVID-19 vaccination for severely immunosuppressed

The Joint Committee on Vaccination and Immunisation (JCVI) is advising that people with severely weakened immune systems should have a third vaccine dose as...
Image of several Coronavirus particles linking to the article: CMA warns PCR COVID-19 test providers against breaching consumer law

CMA warns PCR COVID-19 test providers against breaching consumer law

The CMA has sent an open letter to PCR COVID-19 test providers warning that a range of harmful practices in the sector could breach...
JCVI advises that all UK 16- and 17-year-olds should be offered COVID-19 vaccine

JCVI advises all UK 16- and 17-year-olds should be offered COVID-19 vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice that all 16 to 17-year-olds should be offered a first dose of the...
Study shows AZ’s COVID-19 vaccine did not increase the rate of rare blood clots after second dose

Study shows AZ’s COVID-19 vaccine did not increase rate of rare blood clots after...

Data published in The Lancet has demonstrated that AstraZeneca’s COVID-19 jab Vaxzevria (formerly AZD1222) does not increase the rate of rare blood clots after...
NHS Providers letter states NHS pressures match height of the pandemic

NHS Providers letter states NHS pressures match height of the pandemic

NHS Providers says the health service has, over the last month, become as stretched as it was at the height of the pandemic in...
JCVI advises vaccination for children at increased risk of serious COVID-19

JCVI advises vaccination for children at increased risk of serious COVID-19

The Joint Committee on Vaccination and Immunisation (JCVI) is advising that children at increased risk of serious COVID-19 disease are offered the Pfizer-BioNTech vaccine. That includes children...
A new wave of interest in pharma

COVID: A new wave of interest in pharma, what learnings can we take into...

My Mum, Mary, aged 73, is a retired hairdresser, and this past year she’s discovered a new passion. Medical science. COVID-19 hasn’t left the...
PHE study shows COVID-19 vaccines highly effective in most people in at-risk groups

PHE study shows COVID-19 vaccines highly effective in most people in at-risk groups

A study from Public Health England (PHE), including more than 1 million people in at-risk groups, has demonstrated that COVID-19 vaccines are as effective...

Latest articles

Entries for the Pf Awards 2022 are officially open

Enter today! The Pf Awards 2022 are officially open

New Year | New Suite of Categories | New Candidates Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
New study to explore if talazoparib could treat metastatic breast cancer

New study to explore if talazoparib could treat metastatic breast cancer

A new study funded by Breast Cancer Now will explore if the drug talazoparib (Talzenna) could be used to treat people with incurable secondary...
£250 million winter access fund for GPs to boost face to face appointments  

£250m winter access fund for GPs to boost face to face appointments  

The NHS has published a blueprint for improving access to GP appointments for patients alongside supporting GPs and their teams. Surgeries will be provided with additional funding...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...

Pancreatic Cancer Story: James Dadge

James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...

Pancreatic Cancer Story: John William Street

Pancreatic cancer is the 10th most common cancer in the UK, with around 10,000 people diagnosed each year. The disease has the lowest survival...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...

Pharma marketing: UK vs US

    Marketing medicines is a totally different ball game on each side of the pond. The US is the only country, apart from New Zealand, which...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription